Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells

• Hongqing Zhou,
• Mingsheng Liu,
• Tao Shao,
• Pingbo Xie,
• Shaojie Zhu,
• Wei Wang,
• Qiong Miao,
• Jiaxi Peng,
• Peng Zhang

Affiliations

Hongqing Zhou

The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China

Mingsheng Liu

The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China

Tao Shao

The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China

Pingbo Xie

The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China

Shaojie Zhu

The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China

Wei Wang

The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China

Qiong Miao

The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China

Jiaxi Peng

The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China

Peng Zhang

Department of Urology, Chinese People’s Liberation Army (PLA) General Hospital/Chinese PLA Medical Academy, Beijing, China